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I.  BEHAVIOR OF A GENERALIZED SYSTEM WITH A NEGATIVE
FEEDBACK
Consider a simple linear ordinary differential equations (ODE) system:
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This represents a simple differential equations approximation of a biochemical system with a negative
feedback. It captures, however, main aspects of more complex equations systems with a single negative
feedback interaction. In this system the molecular species x and y interact in such a way that x is negatively
regulated by y, whereas y is positively regulated by x. In addition, self-regulation of x and y is included and
considered to be negative. Biochemically speaking, x activates y, whereas y feeds negatively back to x. In
addition, x and y are constitutively downregulated, e.g., by degradation. The Greek letters represent non-
negative rate constants. The external signal S determines the degree of activation of the entire system.
Treatment of linear ODE systems can be found in most standard differential equations textbooks (for a
good example of comprehensive ODE−Βased treatment of biological data see L. Edelstein-Koshet,
Mathematical Models in Biology, McGraw Hill, New York, NY, 1988). The behavior of [1] is determined
by the values of parameters: a = - α - δ and b =  αδ+βγ. We note that we always have: a ≤ 0 and b ≥ 0.
These conditions lead to two possible “phase portraits” of the system: the stable spiral or the stable node.
The stable spiral implies damped oscillations for the values of both x and y when plotted as a function of
time as both variables approach the stable steady state determined by S. The stable spiral is actualized if a2
< 4b. In other words, the lower the value of a compared to b, the more “oscillatory” or less damped the
behavior. The limiting case of a = 0 (corresponding to “center”, see above) generates undamped
oscillations. A related result is that the value of a determines how fast the system relaxes to the steady state
value, whereas the value of b determines the frequency of the oscillations.
The above treatment interpreted biochemically means that the higher the feedback regulation terms
(represented by b) compared to self-regulation terms (represented by a), the less damped (or more
pronounced) is the oscillatory response to changes in the external signal S.  The frequency of the
oscillations is inversely proportional to b.  Therefore an increase in system parameters determining b for [1]
will strengthen the negative feedback but will also increase the propensity for oscillations in the response.
In some biochemical systems with negative feedbacks oscillations can thus arise as a by-product of the
necessity of fast signal down-regulation.
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II.  DESCRIPTION OF THE MODEL
Introduction
The focus of the model is the central signaling module that appears to transduce all NF-κB responses.  It
consists of IKK represented here as a single signaling entity (without separate descriptions for IKK1/IKK2
(IKKα/IKKβ) heterodimer scaffolded by NEMO (IKKγ)), three mammalian IκB isoforms (α,β and ε), and
NF-κB.  NF-κB heterodimer isoforms are not specified in this model, a simplification that has two
justifications: (1) A single NF-κB isoform (p50/p65) with transcriptional activation potential predominates
in many cells.  (2) IκB-NF-κB interaction appears to be promiscuous with little molecular preferences
evident in NF-κB/Rel or IκB protein knockouts (A. Hoffmann, unpublished data).  While future version of
the model may consider the substructure of multi-protein complexes, the present model is adequate in
addressing the role of different IκB isoforms in controlling the dynamic response of the pathway to
transient and persistent stimulation.
The model consists of a series of ordinary differential equations describing the time evolution of
concentrations of various molecules and molecular complexes of interest. In particular, nuclear NF-κB,
bimolecular IKK-IκB, IκB-NF-κB and trimolecular IKK-IκB-NF-κB complexes for each IκB isoform are
explicitly considered. The participating molecular species are assumed to translocate between two
subcellular compartments: the cytoplasm and the nucleus, thus necessitating considerations about transport
rates in addition to binding and reaction rates. The input into the signaling module is represented by the
concentration of the active IKK. This assumption allows the model to be applied to a variety of ligands –
different ligands may, however, lead to different IKK activation profiles via signaling modules that are not
subject of this study.  Further, we assumed that ubiquitination and proteolysis of IκB isoforms follows
immediately the specific phosphorylation event of IκB by IKK.  While we can represent the whole process
by a single reaction rate here, future versions of the model will distinguish between these steps as more
biochemical data becomes available.  Thus the interaction of IKK and IκB isoforms effectively proceeds as
a single enzymatic degradation reaction scheme:
E + S  ES  E,
where E is the enzyme, S is the substrate and ES is the enzyme-substrate complex. This reaction scheme
gives rise to three differential equations describing the rates of change of the concentrations of E, S and ES.
In the computational model all four rates are described explicitly. In general, enzymes, substrates and
products of individual reactions can be shared among multiple reactions giving rise to more complex
differential equations for the corresponding concentrations. Thus, in order to describe changes in the
concentration of a reaction component completely, all reactions that this component participates in, plus
possible transport, degradation and complex formation rates must be considered.
Nomenclature
Uppercase letters denote concentrations of molecular species.  All are proteins, except those subscripted
with t, which are relevant messenger RNA transcripts.
Lower case letters with numbers represent the corresponding model parameters.
Uncomplexed molecules are described by the designated symbol immediately followed by (t).
Complexes of molecules are described by the designated symbols of their component molecules written
next to each other without separation by (t).
The subscripted n indicates that the molecule is in the nucleus.
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Free cytoplasmic NF-κB protein
The first two lines represent the depletion of free NF-κB due to formation of IκB-NF-κB complexes (the
terms containing the association rate constants a4, a5, a6) and formation of free NF-κB due to dissociation
of these complexes (the terms containing the dissociation rate constants d4, d5, d6).
The next three lines describe the changes in the concentration of free NF-κB due to binding to and
dissociation from binary IKK-IκB complexes and freeing of NF-κB due to IκB degradation in these
complexes following its phosphorylation by IKK (the reaction rate terms are r4, r5 and r6).
The next line describes the rate of degradation of IκB isoforms in IκB-NF-κB complexes (the terms with
the degradation rate constant deg4 assumed to be equal for all the isoforms).
The final line of the equation represents the first order transport terms for the transport of NF-κB into (the
rate constant k1) and out of the nucleus (the rate constant k01).
NF-κB'(t) =  -a4 ΙκΒα(t)  NF-κB(t) + d4 ΙκΒα NF-κB(t)-a5 ΙκΒβ(t)  NF-κB(t) + d5 ΙκΒβ NF-κB(t)
-a6 ΙκΒε(t)  NF-κB(t) + d6 ΙκΒε NF-κB(t)
-a4 IKKΙκΒα(t)  NF-κB(t) + (r4 + d4) IKKΙκΒα NF-κB(t)
-a5 IKKΙκΒβ(t)  NF-κB(t) + (r5 + d5) IKKΙκΒβ NF-κB(t)
-a6 IKKΙκΒε(t)  NF-κB(t) + (r6 + d6) IKKΙκΒε NF-κB(t)
+deg4 ΙκΒα NF-κB(t) + deg4 ΙκΒβ NF-κB(t) + deg4 ΙκΒε NF-κB(t)
 -k1  NF-κB(t) + k01  NF−κΒn (t),
Free nuclear NF-κB protein
The terms describe transport into and out of the nucleus, and sequestration through nuclear IκB isoforms.
 NF−κΒn '(t) =  k1 NF−κΒ(t) - a4 ΙκΒαn(t)  NF−κΒn(t) + d4 ΙκΒαn NF−κΒn (t) -
    a5 ΙκΒβn(t)  NF−κΒn (t) + d5 ΙκΒβn NF−κΒn (t) - a6 ΙκΒεn(t)  NF−κΒn(t) +
    d6 ΙκΒεn NF−κΒn(t) - k01  NF−κΒn (t),
IκB mRNA transcript levels
An accurate mathematical account of regulation of transcription and translation is difficult because of
inherent complexity of the underlying regulatory processes that are still to a large measure unknown. We
have thus given simple semi-qualitative descriptions of the dependence of the rates of transcription and
translation on the concentration of NF-κB and the concentration of IκB transcripts. We have opted to
include separate descriptions of transcription and translation since the data on mRNA concentration as a
function of time are increasingly available through DNA microarray and other technologies.  The
transcription of IκB isoforms was assumed to be a second order process proportional to the square of
nuclear NF-κB concentration for IκBα and zero order constitutive processes for all three isoforms.  The
second order dependence of inducible IκBα transcription was introduced to capture the fact that NF-κB is a
dimer and as such can be presumed to bind DNA in a non-linear, cooperative fashion.  This non-linearity,
however, is not essential for the qualitative behavior of the model, as can be easily shown computationally.
The degradation of IκB mRNA transcripts was described according to unsaturable first order kinetics for all
isoforms. The sensitivity of the model to variations of the synthesis and degradation rates is examined in
Supplement 3 and Fig. 6 of the paper.
ΙκΒαt'(t) = tr2a + tr2  NF−κΒn(t)2 - tr3 ΙκΒαt(t),
ΙκΒβt'(t) = tr2b - tr3 ΙκΒβt(t),
ΙκΒεt'(t) = tr2e - tr3 ΙκΒεt (t),
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Free cytoplasmic IκB proteins
The equations account for cytoplasmic sequestration by IKK (association and dissociation rate constants:
a1 and d1 for IκBα, a2 and d2 for IκBβ and a3 and d3 for IκBε) and NF-κB, nuclear transport (with the
rate of import tp1 and export tp2 assumed to be equal for all isoforms), synthesis (the rate of translation tr1)
and constitutive degradation (deg1 assumed to be equal for all isoforms).
ΙκΒα'(t) = -a1 IKK(t) ΙκΒα(t) + d1 IKKΙκΒα(t) - a4 ΙκΒα(t)  NF−κΒ(t) +
    d4 ΙκΒα NF−κΒ(t) + tr1 ΙκΒαt(t) - deg1 ΙκΒα(t) - tp1 ΙκΒα(t) +
    tp2 ΙκΒαn(t),
ΙκΒβ'(t) = -a2 IKK(t) ΙκΒβ(t) + d2 IKKΙκΒβ(t) - a5 ΙκΒβ(t)  NF−κΒ(t) +
    d5 ΙκΒβ NF−κΒ(t) + tr1 ΙκΒβt(t) - deg1 ΙκΒβ(t) – 0.5 tp1 ΙκΒβ(t) +
    0.5 tp2 ΙκΒβn(t),
ΙκΒε'(t) = -a3 IKK(t) ΙκΒε(t) + d3 IKKΙκΒε(t) - a6 ΙκΒε(t)  NF−κΒ(t) +
    d6 ΙκΒε NF−κΒ(t) + tr1 ΙκΒεt(t) - deg1 ΙκΒε(t) – 0.5 tp1 ΙκΒε(t) +
   0.5 tp2 ΙκΒεn(t),
Free nuclear IκB proteins
Nuclear concentrations of IκB isoforms are determined by nuclear transport and binding to nuclear NF-κB.
ΙκΒαn'(t) =  tp1 ΙκΒα(t) - tp2 ΙκΒαn (t) - a4 ΙκΒαn (t)  NF−κΒn(t) + d4 ΙκΒαn NF−κΒn(t),
ΙκΒβn'(t) =  0.5 tp1 ΙκΒβ(t) – 0.5 tp2 ΙκΒβn (t) - a5 ΙκΒβn (t)  NF−κΒn(t) + d5 ΙκΒβn NF−κΒn(t),
ΙκΒεn'(t) =  0.5 tp1 ΙκΒε(t) – 0.5 tp2 ΙκΒεn' (t) - a6 ΙκΒεn(t)  NF−κΒn(t) + d6 ΙκΒεn NF−κΒn(t),
Cytoplasmic IκB-NF-κB complexes
Their presence is determined by binding rates and constitutive IκB degradation.
ΙκΒα NF−κΒ'(t) =  a4 ΙκΒα(t)  NF−κΒ(t) - d4 ΙκΒα NF−κΒ(t) - a7 IKK(t) ΙκΒα NF−κΒ(t) +
    d1 IKKΙκΒα NF−κΒ(t) + k2 ΙκΒαn NF−κΒn(t) - deg4 ΙκΒα NF−κΒ(t),
ΙκΒβ NF−κΒ'(t) =  a5 ΙκΒβ(t)  NF−κΒ(t) - d5 ΙκΒβ NF−κΒ(t) - a8 IKK(t) ΙκΒβ NF−κΒ(t) +
    d2 IKKΙκΒβ NF−κΒ(t) + 0.4 k2 ΙκΒβn NF−κΒn(t) - deg4 ΙκΒβ NF−κΒ(t),
ΙκΒε NF−κΒ'(t) =  a6 ΙκΒε(t)  NF−κΒ(t) - d6 ΙκΒε NF−κΒ(t) - a9 IKK(t) ΙκΒε NF−κΒ(t) +
    d3 IKKΙκΒε NF−κΒ(t) +0.4 k2 ΙκΒεn NF−κΒn(t) - deg4 ΙκΒε NF−κΒ(t),
Nuclear IκB-NF-κB complexes
The equations above are balanced by the corresponding equations describing the formation of the nuclear
IκB-NF-κB complexes. IκBβ-NF-κB and IκBε-NF-κB complexes are transported with the rates equal to
0.5 of the rate of IκBα-NF- κB complexes (tp2). (see Parameter Estimation)
ΙκΒαn NF−κΒn'(t) = a4 ΙκΒαn(t)  NF−κΒn(t) - d4 ΙκΒαn NF−κΒn(t) - k2 ΙκΒαn NF−κΒn(t),
ΙκΒβn NF−κΒn'(t) =  a5 ΙκΒβn (t)  NF−κΒn(t) - d5 ΙκΒβn NF−κΒn(t) – 0.5  k2 ΙκΒβn NF−κΒn(t),
ΙκΒεn NF−κΒn'(t) =  a6 ΙκΒεn(t)  NF−κΒn(t) - d6 ΙκΒεn NF−κΒn(t) - 0.5 k2 ΙκΒεn NF−κΒn(t),
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Free cytoplasmic IKK protein
Accounting for adaptation to the signal, binding rates and IκB degradation due to IKK activity.
IKK'(t) = -k02 IKK(t) - a1 IKK(t) ΙκΒα(t) + (d1 + r1) IKKΙκΒα(t) -
    a2 IKK(t) ΙκΒβ(t) + (d2 + r2) IKKΙκΒβ(t) -
    a3 IKK(t) ΙκΒε(t) + (d3 + r3) IKKΙκΒε(t) -
    a7 IKK(t) ΙκΒα NF−κΒ(t) + (d1 + r4) IKKΙκΒα NF−κΒ(t) -
    a8 IKK(t) ΙκΒβ NF−κΒ(t) + (d2 + r5) IKKΙκΒβ NF−κΒ(t) -
    a9 IKK(t) ΙκΒε NF−κΒ(t) + (d3 + r6) IKKΙκΒε NF−κΒ(t),
Cytoplasmic IKK-IκB complexes
Accounting for binding rates and IκB degradation due to IKK activity.
IKKΙκΒα'(t) = a1 IKK(t) ΙκΒα(t) - (d1 + r1) IKKΙκΒα(t) - a4 IKKΙκΒα(t)  NF−κΒ(t) +
    d4 IKKΙκΒα NF−κΒ(t),
IKKΙκΒβ'(t) = a2 IKK(t) ΙκΒβ(t) - (d2 + r2) IKKΙκΒβ(t) - a5 IKKΙκΒβ(t)  NF−κΒ(t) +
    d5 IKKΙκΒβ NF−κΒ(t),
IKKΙκΒε'(t) = a3 IKK(t) ΙκΒε(t) - (d3 + r3) IKKΙκΒε(t) - a6 IKKΙκΒε(t)  NF−κΒ(t) +
    d6 IKKΙκΒε NF−κΒ(t),
Cytoplasmic IKK-IκB-NF-κB complexes
Accounting for binding rates between IKK-IκB complexes and NF-κB, as well as IκB-NF-κB complexes
and IKK, and IκB degradation due to IKK activity.
IKKΙκΒα NF−κΒ'(t) =  a7 IKK(t) ΙκΒα NF−κΒ(t) +
 a4 IKKΙκΒα(t)  NF−κΒ(t) - (d1 + d4 + r4) IKKΙκΒα NF−κΒ(t),
IKKΙκΒβ NF−κΒ'(t) =  a8 IKK(t) ΙκΒβ NF−κΒ(t) +
    a5 IKKΙκΒβ(t)  NF−κΒ(t) - (d2 + d5 + r5) IKKΙκΒβ NF−κΒ(t),
IKKΙκΒε NF−κΒ'(t) =  a9 IKK(t) ΙκΒε NF−κΒ(t) +
    a6 IKKΙκΒε(t)  NF−κΒ(t) - (d3 + d6 + r6) IKKΙκΒε NF−κΒ(t),
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I. PARAMETER VALUES IN THE LITERATURE
1. IκB mRNA and protein half-lifes
The IκB mRNA half-life is estimated to be 30min. - 2 hrs. (11), which constrains the rate constant for IκB
mRNA transcript degradation to 0.0004 s-1 to 0.0001 s-1.
IκB protein half-life (signal-independent) complexed to NF-κB: 550 min; half-life of free IκB: 110 min.(3)
The rate of constitutive IκB degradation when bound to NF-κB is ln2/(550*60 s) = 0.00002 s-1
and when not bound to NF-κB is ln2/(110*60 s) = 0.0001 s-1.
2. Interactions between IKK, IκB and NF-κB
IKK-IκB interaction (in the absence of NF-κB):
The following data are from (4).
Table 1: Kinetics for the interaction between IKK2 and the IκB Isoforms
IκB isoform ka (M-1 s-1) kd (s-1) KDa (M) = kd/ka
IκBα 22.5 (±2.5) _ 103 1.25 (±0.15) _ 10-3 56 _ 10-9
IκBβ1 10.5 (±1.5) _ 103 1.25 (±0.15) _ 10-3 119 _ 10-9
IκBβ2 6.0 (±1.0) _ 103 1.75 (±0.15) _ 10-3 292 _ 10-9
IκBε 9.0 (±2.0) _ 103 1.75 (±0.15) _ 10-3 194 _ 10-9
Table 2: Kinetic parameters KM and kcat for the phosphorylation of the IκB isoforms by IKK
IκB isoform KM (M) kcata (s-1) kcat/KMb (s-1 M-1)
IκBα 1.7 (±0.6) _ 10-6 3.7 _ 10-2 22 _ 103
IκBβ1 3.2 (±1.1) _ 10-6 3.2 _ 10-2 10 _ 103
IκBβ2 2.8 (±1.0) _ 10-6 1.5 _ 10-2 5.4 _ 103
IκBε 2.6 (±0.4) _ 10-6 2.2 _ 10-2 8.5 _ 103
It is reported in (5) that kcata ≈ 10-2 s-1 and KM = 0.6-1 µM in general agreement with the values above.
These values allow us to deduce rate constants for associations dissociation and catalysis:
IκB isoform ka (µM-1 s-1) kd (s-1) kcat (s-1)
IκBα 22.5 _ 10-3 1.25 _ 10-3 3.7 _ 10-2
IκBβ 6.0 _ 10-3 1.75  _ 10-3 1.5 _ 10-2
IκBε 9.0 _ 10-3 1.75  _ 10-3 2.2 _ 10-2
IKK-IκB interaction (in the presence of NF-κB):
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The existence of the tripartite IKK-IκB-NF-κB complex has been demonstrated in (1).
Zandi et al. report that “Kinetic analysis indicated that in the presence of NF-κB, the Km for IκB 
phosphorylation by IKK decreased from 2.2 µM to 1.4 µM and the relative maximum  initial velocity Vmax
(or kcata ) was increased by a factor of 5.” (2)
Thus we conclude that in the presence of NF-κB kcat is increased by a factor of 5, and ka is increased 7-8-fold:
IκB isoform ka (µM-1 s-1) kd (s-1) kcat (s-1)
IκBα 1.85 _ 10-1 1.25 _ 10-3 1.85 _ 10-1
IκBβ 4.8 _ 10-2 1.75  _ 10-3 7.5 _ 10-2
IκBε 7.0 _ 10-2 1.75  _ 10-3 1.1 _ 10-1
IκB-NF-κB interactions:
Affinity is estimated as being on the order of 1 nM (6), with the dissociation rate constant assumed to be
around 0.001 s-1 in (7), and association and dissociation rate constants estimated at 18.4 µM-1min-1 and
0.055min-1 in (6). There is no data on differential affinity constants for IκB isoforms.
Though these values are somewhat conflicting, they constrain our parameter fitting to
ka = 0.3 µM-1 s-1 - 1 µM-1 s-1 and kd = 0.0003 s-1 - 0.001 s-1.
3. Cytoplasmic-Nuclear Transport
The transport characteristics of IκB and NF-κB and the concentration of NF-κB are examined in (7).
While IκBα-NF-κB complexes are largely cytoplasmic, free NF-κB is largely nuclear.  IκBα
overexpression studies suggest that the ratio of the transport parameters is kimp/kexp ∼ 2.  We assume that to
be the same for IκBβ and –ε.
The time constant of the nuclear import of IκBα is estimated to be within the 0.01-0.07 min-1 range.  These
observations constrain IκB import to 1.7-11.7 10-4 s-1 and IκB export to 0.8 - 5.8 10-4 s-1.
It is also noted in (7) and (8) that IκB-NF-κB complex dissociates such that IκB and NF-κB to enter the
nucleus independently, which means that nuclear import of the IκB-NF-κB complex is zero.
When nuclear export is blocked with the small molecule inhibitor leptomycin B, IκBβ and IκBε show
significantly less nuclear accumulation than IκBα (10).  To reflect that observation, we multiplied the
relevant transport terms by a factors of 0.4 or 0.5 in the equations.
However, upon TNF stimulation newly synthesized IκBβ accumulates in the nucleus, binding NF-κB-DNA
complexes (9).  To account for this phenomenon, we have included a term that controls the fraction of IκBβ
molecules that are subject to export with respect to time: fr’[t]=-.5/(1+t)^2, fr[0]=.5
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II. MODEL FITTING PROCEDURES FOR PARAMETER ESTIMATION
Introduction
Most parameter values in the model have been taken directly from the literature, as described above. Other
parameter values are constrained by published results.  The parameters that were varied during model
fitting to the experimental data in Fig. 2 were the rates of transcription and translation of ΙκΒ isoforms and
the rate of ΙκΒ−NF-κΒ nuclear export and NF-κB nuclear import. Note that, since only one ΙκΒ isoform is
present in each knockout cell line, the rates of synthesis of each given isoform can be adjusted
independently. The rates of translation were assumed to be equal for all isoforms involved. In the parameter
estimation it was determined that an increase in the rates of ΙκΒ isoform transcription could be almost
exactly compensated by a proportional decrease in the rate of translation. The translation rate was chosen to
correspond to a 3-4 min. time constant.
In adjusting the parameters, it is common to use techniques leading to minimization of the sum of squares
of the differences between the predicted and actual responses. Among these methods are the gradient
descent method, the Levenberg-Marquardt method, the direct search method of Hooke and Jeeves, etc. (see
(12) for extended reference list and discussion). However, given a sufficiently complex biochemical
network the performance of these methods can be quite poor (13). In addition, these fitting techniques
applied to oscillatory behavior skew towards optimizing frequency matches rather than amplitude and
overall qualitative shape of the curve, since a small shift in frequency (and the time of the onset of the
oscillations) can lead to a substantial increase in the sum of residuals. On the other hand the fitting process
is already significantly constrained by the values for previously published parameters.
Reduced model fitting to knock-out cell line data
We first utilized the steepest gradient descent (GD), genetics algorithm (GA) and random search parameter
estimation in the Gepasi version 3.1 software package.  Random search parameter estimation yielded the
best results among several fitting methods as evidenced by the standard deviation of the estimated
parameter values.  The most challenging model fitting task represents the oscillatory NF-κB activation
profile in IκBβ-/-IκBε-/- cells.  As shown in Fig.S1, there is satisfactory fit at early time points, but the
resulting model fails to describe faithfully the overall shape and frequency of oscillations. In particular,
there is a considerable overestimation of the degree of the oscillation damping.
Next, we used the parameter estimates derived from the random method and varied them within the
standard deviation limits to improve the qualitative fits regarding frequency and amplitude of oscillations.
Such qualitative fitting led to a 6% decrease in the estimate of the transcription rate and about a two-fold
decrease in the IκB-NF-κB nuclear export rate (the model was rather insensitive to variations of the latter).
The estimate for the NF-κB nuclear import rate was not readjusted.
Both the ΙκΒα transcription rate and the rate of ΙκΒ-NF-kB nuclear export affect the frequency and the
amplitude (the degree of damping) of the oscillations. We have varied these parameters, as described
above. Similarly, we studied the behavior of the models, in which only ΙκΒβ and ΙκΒε are expressed (these
“knockout” models are generated by equating the rates of transcription for two ΙκΒ isoforms out of three to
zero). These studies resulted in the simulation curves presented in Fig. 2 of the paper.
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Wild type cell model fitting
To generate the model of the wild type fibroblast response, we first assumed that we can simply equate the
transcription rates for all ΙκΒ isoforms to the values determined in double knockout fitting studies.
However, as shown in Fig. 2D, these results failed to agree with the experimental data. The model output
was fitted to the wild type cell experimental data by adjusting the transcription rates for ΙκΒβ and ΙκΒε
only. These rates were adjusted down 7-fold to result in good qualitative approximation of the wild type
behavior. We concluded that it is likely that there is a cross-regulation between ΙκΒ isoforms leading to
compensation of the absence of ΙκΒ isoforms in the knockout lines through up-regulation of the existing
ΙκΒ isoform.  Such parameter adjustment emphasizes that variation of the rates of synthesis of β and ε
isoforms can lead to significant changes in the signaling characteristics.
Conclusion
The goal of this study is not an exact estimation of biochemical parameters.  Parameter sensitivity studies
(A.L. unpublished results) can explore how error in the estimates may affect the system’s response.
Importantly, the conclusions of our study regarding the respective functions of IκB isoforms, the bimodal
signal processing characteristics, and the newly revealed mechanism for specificity in gene expression are
not dependent on exact parameter estimates.  This also suggests that these conclusions are valid in a variety
of cell types, physiological or experimental conditions where parameter values may differ.
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Fig. S1  Comparison of the fitting methods applied to the oscillatory NF-κB activation profile in IκBβ-/-
IκBε-/- cells. The experimental data are shown as black filled circles, the “semi-quantitative” fit is shown
in red and the result of random search fitting in blue. The fitting was performed using the fitting engines
supplied with the Gepasi package, version 3.1 (11).
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III. SUMMARY OF PARAMETER VALUES
We have indicated by black color the values that were previously determined experimentally, and by blue
color the values that were constrained by published results.  Values in red color were derived de novo
during model fitting to our experimental data from cells harboring genetically reduced and wild-type IκB-
NF-κB signaling modules.
Two component interactions: Symbol: Values: Units:
IκBα-NF-κB association a4 0.5 _  100 µM-1 s-1
IκBα-NF-κB dissociation d4 0.5 _ 10-3 s-1
IκBβ-NF-κB association a5 0.5 _  100 µM-1 s-1
IκBβ-NF-κB dissociation d5 0.5 _ 10-3 s-1
IκBε-NF-κB association a6 0.5 _  100 µM-1 s-1
IκBε-NF-κB dissociation d6 0.5 _ 10-3 s-1
IKK-IκBα association a1 22.5 _ 10-3 µM-1 s-1
IKK-IκBα dissociation d1 1.25 _ 10-3 s-1
IKK-IκBα catalysis r1 3.7 _ 10-2 s-1
IKK-IκBβ association a2 6.0 _ 10-3 µM-1 s-1
IKK-IκBβ dissociation d2 1.75 _ 10-3 s-1
IKK-IκBβ catalysis r2 1.5 _ 10-2 s-1
IKK-IκBε association a3 9.0 _ 10-3 µM-1 s-1
IKK-IκBε dissociation d3 1.75 _ 10-3 s-1
IKK-IκBε catalysis r3 2.2 _ 10-2 s-1
Three component interactions: Symbol: Values: Units:
IKK-IκBαNF-κB association a7 1.85 _ 10-1 µM-1 s-1
IKK-IκBαNF-κB dissociation d1 1.25 _ 10-3 s-1
IKKIκBα-NF-κB association a4 0.5 _  100 µM-1 s-1
IKKIκBα-NF-κB dissociation d4 0.5 _ 10-3 s-1
IKKIκBαNF-κB catalysis r4 1.85 _ 10-1 s-1
IKK-IκBβNF-κB association a8 4.8 _ 10-2 µM-1 s-1
IKK-IκBβNF-κB dissociation d2 1.75 _ 10-3 s-1
IKKIκBβ-NF-κB association a5 0.5 _  100 µM-1 s-1
IKKIκBβ-NF-κB dissociation d5 0.5 _ 10-3 s-1
IKKIκBβNF-κB catalysis r5 7.5 _ 10-2 s-1
IKK-IκBεNF-κB association a9 7.0 _ 10-2 µM-1 s-1
IKK-IκBεNF-κB dissociation d3 1.75 _ 10-3 s-1
IKKIκBε-NF-κB association a6 0.5 _  100 µM-1 s-1
IKKIκBε-NF-κB dissociation d6 0.5 _ 10-3 s-1
IKKIκBεNF-κB catalysis r6 1.1 _ 10-1 s-1
Supplement 2: parameter determination - 7 - Hoffmann et al.
Synthesis and degradation: Symbol: Values: Units:
IκBα  inducible mRNA synthesis tr2 1.7 _ 10-1 µM-1 s-1
IκBα constitutive mRNA synthesis tr2a 1.5 _ 10-6  µM s-1
IκBβ constitutive mRNA synthesis tr2b 2.3 _ 10-7 µM s-1
IκBε constitutive mRNA synthesis tr2e 1.7 _ 10-7 µM s-1
IκB mRNA degradation tr3: 2.8 _ 10-4 s-1
constitutive IκB translation rate tr1 4 _ 10-3 s-1
constitutive IκB degradation (free) deg1 1.0 _ 10-4 s-1
constitutive IκB degradation (complexed to NF-_B) deg2 2.1 _ 10-5 s-1
Nucleo-cytoplasmic transport: Symbol: Values: Units:
IκBα nuclear import tp1 3 _ 10-4  s-1
IκBα nuclear export tp2 2 _ 10-4 s-1
IκBβ nuclear import 0.5 tp1 1.5 _ 10-4  s-1
IκBβ nuclear export  fr’[t]=-.5/(1+t)^2 0.5 tp2 1 _ 10-4 s-1
IκBε nuclear import 0.5 tp1 1.5 _ 10-4  s-1
IκBε nuclear export 0.5 tp2 1 _ 10-4 s-1
NF-κB nuclear import k1 0.9 _ 10-1 s-1
NF-κB nuclear export k01 0.8 _ 10-4 s-1
IκBα-NF-κB nuclear export k2 1.4 _ 10-2 s-1
IκBβ-NF-κB nuclear export    fr’[t]=-.5/(1+t)^2 0.4 k2 5.6 _ 10-3 s-1
IκBε-NF-κB nuclear export 0.4 k2 5.6 _ 10-3 s-1
Simulation protocol
As we are considering “active” IKK, all simulations are started with IKK concentration equal to zero.
Following “equilibration” for 2000 min., IKK is raised as a step function to 0.1 µM. We assume that
following the signal onset there is a slow adaptation (k02 = 8.3_10-5 s-1; half-life of 2.3 hrs.), gradually
reducing active IKK concentration.
Signal removal (corresponding to experimental wash of cells to remove TNF) is modeled as adjustment of
the adaptation coefficient k02 to 2.3_10-3 s-1 (half-life of 5 min.).
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BIOCHEMICAL AND MOLECULAR BIOLOGICAL METHODS
Cell lines and cell culture
Human JURKAT and U937 cell lines were grown in DMEM with 10% fetal calf serum and stimulated
with 10ng/ml human TNFα (Biogen). Immortalized fibroblast cell lines were made from E14.5 embryos
according to the 3T3 protocol in 10% calf serum (S.A. Aaronson and G.J. Todaro 1968, J. Cell. Phyisol.
vol. 72, pp. 141-148) and maintained in the same manner.  Subconfluent or confluent-and-starved (0.5%
serum) cells in 10cm polylysine-coated dishes were stimulated with 10ng/ml murine TNFα (Roche).
Electrophoretic Mobility Shift Assay (EMSA)
Following a wash with ice cold phosphate buffered saline (PBS) supplemented with 1mM EDTA, cells
were collected (scraped with a rubber policeman, if necessary) into a microfuge tube tube and pelleted at
2000g.  Cells (about 106) were resuspended and allowed to swell in 100µl CE buffer (10mM Hepes-KOH
pH7.9, 60mM KCl, 1mM EDTA, 0.5% NP-40, 1mM DTT, 1mM PMSF) and vortexed for lysis. Nuclei
were pelleted at 4000g, and cytoplamic lysate removed for SDS-PAGE (following protein concentration
normalization) and standard Western blot analysis.  Antibodies from Santa Cruz Biotechnology, Inc were
used for IκBα (sc-371) and IκBβ (sc-945).  A mouse polyclonal antibody was prepared against full-length
recombinant mouse IκBε protein according to standard procedures.  For EMSA, Nuclei were resuspended
in 30µl NE buffer (250mM Tris pH7.8, 60mM KCl, 1mM EDTA, 1mM DTT, 1mM PMSF) and lysed by
3 freeze-thaw cycles.  Nuclear lysates are cleared by 14000g centrifugation and adjusted to 1µg/µl total
protein concentation following Bradford assay.  2µg of total nuclear protein was reacted at room
temperature for 15min. to 0.1pmoles of P32-labelled 30pb double-stranded oligonucleotide containing a
consensus κB-site (AGCTTGCTACAAGGGACTTTCCGCTGTCTACTTT) in 6µl binding buffer
(10mM Tri.Cl pH7.5, 50mM NaCl, 10% glycerol, 1% NP-40, 1mM EDTA, 0.1µg/µl polydIdC).
Complexes were resolved on a non-denaturing 5% acrylamide (30:0.8) gel containing 5% glycerol and 1x
TGE (24.8mM Tris, 190mM glycine, 1mM EDTA) and visualized by standard autoradiography and/or
quantitated using a Phosphoimager (Molecular Dynamics), in which the unbound probe (>20 fold excess)
was used to normalize for loading variability.  Graphed data is 1000x(signal–background)/(unbound
probe–background).
RNAse Protection Assay (RPA)
Total RNA was made from confluent and starved fibroblasts using Tri-Reagent (Molecular Research
Center, Inc).  RNase Protection Analysis was performed with 5µg RNA using Riboquant probe set mCK-5
(Pharmingen) according to manufacturers instructions.
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Generation of the IkBε-/- mouse.
The targeting construct results in a deletion of Amino acids 145-343 of IκBε and hence disruption of all 6
ankyrin repeats.  Standard methods were utilized in the ES cell selection, the deletion blastocyst injections
and derivation of a knock-out mouse strain.  The targeting construct was generated as follows:
1. Two overlapping clones spanning approximately 20 kb of 129SvJ genomic DNA and containing the
entire IκBε coding sequence were subcloned from lambda FIXII (Stratagene)  into pBSK(+).  These
subclones, referred to as 8A21H and 10A44, were extensively mapped by restriction digestion and
oligonucleotide hybridization.
2. A 2.0 kb Bgl2-Xho1 fragment from 8A21H that contained the first coding exon of IκBε was blunted
with Klenow polymerase and gel isolated.  The fragment was then ligated to a Pme1-digested knockout
vector, pLNTKP (kindly provided by F. Alt).  This yielded a cloning intermediate called pEK1.  The
presence of IκBε coding nucleotides 1-345 just upstream of the neomycin resistance cassette, at the
(Xho1)-vector junction of pEK1, was confirmed by DNA sequencing.  
3. Oligonucleotide linkers containing a Xho1 recognition site were ligated to a 7.3 kb Bgl2 fragment of
subclone 10A44 ;  the fragment was gel purified and cut with Xho1.  This fragment was then ligated to
pEK1 DNA previously treated with Xho1 and alkaline phosphatase to give a final knockout construct,
pEK7.
4. DNA sequencing of pEK7, beginning in the neomycin resistance cassette and extending downstream
into genomic DNA, revealed an exon composed of coding nucleotides 1029-1102 of IκBε.  The
intron/exon sequence of the deleted portion of genomic DNA was not determined.  Therefore, intervening
exons are not indicated in the accompanying diagram.
5. The pEK7 construct was linearized with Pac1 and introduced into E14 ES cells by standard methods.  A
hybridization probe derived from an upstream Bgl2-EcoRV fragment was used to screen HindIII-digested
DNA from neo-resistant ES cell colonies as indicated in the accompanying diagram.
